CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ICP Biotechnology Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ICP Biotechnology Limited
3 Hutton Centre Drive
Santa Ana, CA  92707  United States Ticker: BIOBIO

This company is no longer actively traded on any major stock exchange.

Business Summary
ICP Biotechnology Limited (ICP) is engaged in manufacturing biological products for the biotechnology, animal and human pharmaceutical industries. This includes new serum products for cell growth and cell culture all for use in the biotech and pharmaceutical industries. The Company manufactures and markets products for use in biopharmaceutical manufacturing, diagnostics and animal reproduction to North America, Europe, Asia and South America. ICP’s product portfolio comprised Albumin, Emcare and Ovagen. The Company’s cornerstone range of products is its embryo transfer (ET) products. ICP manufactures products that biopharmaceutical companies use to make, test, store or deliver their products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20076/30/2007Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Roger H.Gower 5/12/2006 10/1/2003
Chief Executive Officer SanneMelles 7/13/2007 2/12/2007
Non-Executive Director Brent D.King 9/1/2006 9/1/2006
Independent Non-Executive Director Alistair A.Ward 12/1/2000 12/1/2000

Business Names
Business Name
Australasian Property Holdings Group Ltd
BIO
ICP Biotechnology Limited

General Information
Number of Employees: 90 (As of 12/31/2006)
Outstanding Shares: 432,616,076 (As of 12/31/2007)
Shareholders: 5,538
Stock Exchange: NZE


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023